The weekly litigation news digest is live. Subscribe now

IP Verse

Immunogenic Mutant Peptide Screening Platform - EP3194970

The patent EP3194970 was granted to F Hoffmann LA Roche on Jul 28, 2021. The application was filed on Sep 10, 2015 under application number EP15772084A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3194970

F HOFFMANN LA ROCHE
Application Number
EP15772084A
Filing Date
Sep 10, 2015
Status
Granted And Under Opposition
Jun 25, 2021
Publication Date
Jul 28, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BISCHOF & PARTNER RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBApr 27, 2022-WITHDRAWN

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20040000474
DESCRIPTIONUS8349558
INTERNATIONAL-SEARCH-REPORTUS2010151492
INTERNATIONAL-SEARCH-REPORTUS2011257890
INTERNATIONAL-SEARCH-REPORTWO2012159643
INTERNATIONAL-SEARCH-REPORTWO2014012051

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents